Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension

Chest. 2002 Mar;121(3 Suppl):50S-53S. doi: 10.1378/chest.121.3_suppl.50s.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Protein Receptors, Type II
  • Bone Morphogenetic Proteins / genetics
  • Bone Morphogenetic Proteins / metabolism
  • Dexfenfluramine / adverse effects
  • Fenfluramine / adverse effects
  • Gaucher Disease / complications
  • Humans
  • Hypertension, Pulmonary / chemically induced
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / genetics*
  • Hypertension, Pulmonary / metabolism
  • Mutation*
  • Protein Serine-Threonine Kinases / genetics*
  • Risk Factors
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Transforming Growth Factor beta
  • Fenfluramine
  • Dexfenfluramine
  • Protein Serine-Threonine Kinases
  • BMPR2 protein, human
  • Bone Morphogenetic Protein Receptors, Type II